Article in Science advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
15 authors.
Andréa L RochaClayton Foundation Laboratories for Peptide Biology, Salk Institute for Biological Studies, La Jolla, CA, USA.ORCID 0000-0002-9044-980X
Christian SchmedtGenomics Institute of the Novartis Research Foundation, 10675 John Jay Hopkins Drive, San Diego, CA, USA.
Guy PerkinsNational Center for Microscopy and Imaging Research, Center for Research in Biological Systems, Department of Neurosciences, School of Medicine, University of California, San Diego, La Jolla, CA, USA.ORCID 0000-0002-1834-6646
Antonio PintoClayton Foundation Laboratories for Peptide Biology, Salk Institute for Biological Studies, La Jolla, CA, USA.ORCID 0000-0002-1573-8011
Jolene K DiedrichMass Spectrometry Core for Proteomics and Metabolomics, Salk Institute for Biological Studies, 10010 North Torrey Pines Road, La Jolla, CA, USA.ORCID 0000-0001-6489-4558
Huanqi ShanClayton Foundation Laboratories for Peptide Biology, Salk Institute for Biological Studies, La Jolla, CA, USA.ORCID 0009-0009-2391-9072
Kaja PlucińskaLaboratory of Molecular Metabolism, Rockefeller University, New York, NY, USA.ORCID 0000-0002-2144-7712
Eduardo Vieira de SouzaClayton Foundation Laboratories for Peptide Biology, Salk Institute for Biological Studies, La Jolla, CA, USA.ORCID 0000-0003-2773-8550
Joan M VaughanClayton Foundation Laboratories for Peptide Biology, Salk Institute for Biological Studies, La Jolla, CA, USA.
Mark FosterClayton Foundation Laboratories for Peptide Biology, Salk Institute for Biological Studies, La Jolla, CA, USA.ORCID 0009-0007-0971-2679
Srinath C SampathGenomics Institute of the Novartis Research Foundation, 10675 John Jay Hopkins Drive, San Diego, CA, USA.ORCID 0009-0003-2451-3388
Srihari C SampathGenomics Institute of the Novartis Research Foundation, 10675 John Jay Hopkins Drive, San Diego, CA, USA.
Paul CohenLaboratory of Molecular Metabolism, Rockefeller University, New York, NY, USA.ORCID 0000-0002-2786-8585
Mark H EllismanNational Center for Microscopy and Imaging Research, Center for Research in Biological Systems, Department of Neurosciences, School of Medicine, University of California, San Diego, La Jolla, CA, USA.ORCID 0000-0001-8893-8455
Alan SaghatelianClayton Foundation Laboratories for Peptide Biology, Salk Institute for Biological Studies, La Jolla, CA, USA.
Funding
Viral Vector Core (VVC)P30CA014195 · NCI · SALK INSTITUTE FOR BIOLOGICAL STUDIES · PI Alan Saghatelian · 1985 to 2026
$82.8M
An Encyclopedia of the Adipose Tissue Secretome to Identify Mediators of Health and DiseaseRC2DK129961 · NIDDK · ROCKEFELLER UNIVERSITY · PI CHAIT, BRIAN T, COHEN, PAUL · 2021 to 2025
$9.2M
The Discovery of Human Peptide Encoding GenesR01GM102491 · NIGMS · SALK INSTITUTE FOR BIOLOGICAL STUDIES · PI O'SHEA, CLODAGH, SAGHATELIAN, ALAN · 2012 to 2025
$5.5M
National Center for Microscopy and Imaging Research: A BRAIN Technology Integration and Dissemination ResourceU24NS120055 · NINDS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ELLISMAN, MARK H · 2021 to 2025
$5.4M
3D Reconstruction and Analysis of Alzheimer's Patient Biopsy Samples to Map and Quantify Hallmarks of Pathogenesis and VulnerabilityR01AG065549 · NIA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ELLISMAN, MARK H · 2020 to 2024
$4.1M
Reversing Microglial Inflammarafts and Mitochondrial Dysfunction in Alzheimer's DiseaseR01AG081037 · NIA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Mark H Ellisman, WONKYU JU · 2023 to 2026
$3.1M
Scalable electron tomography for connectomicsRF1MH129261 · NIMH · HARVARD MEDICAL SCHOOL · PI ELLISMAN, MARK H, LEE, WEI-CHUNG ALLEN · 2022 to 2022
$2.9M
Circadian Structural Plasticity in Central PacemakersR01NS108934 · NINDS · UNIVERSITY OF WASHINGTON · PI CERIANI, MARIA FERNANDA, DE LA IGLESIA, HORACIO O · 2020 to 2024
$2.9M
FEI TITAN HALO 300kV INTERMEDIATE VOLTAGE ELECTRON MICROSCOPES10OD021784 · OD · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ELLISMAN, MARK H · 2017 to 2017
$1.9M
Advancing Multi-Color EM via Direct Detector-enabled 4D-STEMR01GM138780 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ELLISMAN, MARK H · 2020 to 2023
$1.7M
The complex interaction between Alzheimer drivers and agingR01AG062479 · NIA · UNIVERSITY OF CALIFORNIA SANTA BARBARA · PI KOSIK, KENNETH STEPHEN · 2024 to 2024
Uncovering the role of upstream open reading frames (uORFs) challenges conventional views of one protein per messenger RNA and reveals the capacity of some uORFs to encode microproteins that contribute to cellular biology and physiology. This study explores the functional role of a recently identified mitochondrial microprotein, SLC35A4-MP, in the brown adipose tissue of mice. Our findings reveal dynamic regulation of SLC35A4-MP expression during primary brown adipocyte differentiation in vitro and during cold exposure or high-fat diet (HFD)-induced obesity in mice. Using a knockout mouse model, we show that loss of SLC35A4-MP disrupts mitochondrial lipid composition, decreasing cardiolipins and phosphatidylethanolamine in brown adipose tissue from HFD-fed mice. SLC35A4-MP deficiency also impairs mitochondrial activity, alters mitochondrial number and morphology, and promotes inflammation. Knockout mice accumulate acylcarnitines during cold exposure, indicating defective fatty acid oxidation. These findings reveal SLC35A4-MP as a previously unrecognized microprotein in regulating mitochondrial function and tissue lipid metabolism, adding to the growing list of functional endogenous microproteins.
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Abnormal mitochondrial structure and function in brown adipose tissue of SLC35A4-MP knockout mice. · full record | OpenQuestion